Bausch Health Companies INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NYSE
SCHEDULE: Icahn Completes Bausch Health Divestment
Carl Icahn and affiliated entities have fully divested their stake in Bausch Health Companies Inc., selling over 34.7 million shares at $9.00 each.
NYSE
Paulson & Co. Inc. has significantly increased its beneficial ownership in Bausch Health Companies Inc. to 19.1% through recent share purchases.
NYSE
Paulson & Co. Inc. has significantly increased its beneficial ownership in Bausch Health Companies Inc. to 8.9% through a series of recent common share acquisitions.
NYSE
Paulson & Co. Inc. has updated its beneficial ownership in Bausch Health Companies Inc. to 7.1% and entered into a new governance agreement with the company, restricting certain activist actions in exchange for board representation commitments.
NYSE
Carl Icahn's investment entities have entered into a supplemental agreement with Bausch Health Companies Inc., adjusting terms related to board representation and voting rights for their designees.
NYSE
SCHEDULE 13D: Activist Investor Alex Meruelo Discloses 9.99% Stake in Bausch Health, Seeks Board Representation and Strategic Changes
Activist investor Alex Meruelo has disclosed a nearly 10% beneficial ownership stake in Bausch Health Companies Inc., signaling his intent to join the board and influence strategic decisions to enhance shareholder value.